These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15083185)

  • 21. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
    Nakashiro K; Hayashi Y; Oyasu R
    Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
    Wagatsuma S; Konno R; Sato S; Yajima A
    Cancer; 1998 Feb; 82(3):520-30. PubMed ID: 9452270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.
    Felix AS; Edwards RP; Stone RA; Chivukula M; Parwani AV; Bowser R; Linkov F; Weissfeld JL
    Br J Cancer; 2012 Jun; 106(12):2004-9. PubMed ID: 22617129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M; Vitarelli E; Grosso M; Alesci S; Benvenga S; Trimarchi F; Barresi G
    Eur J Histochem; 2004; 48(3):291-7. PubMed ID: 15590419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study.
    Okano J; Shiota G; Kawasaki H
    Liver; 1999 Apr; 19(2):151-9. PubMed ID: 10220746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.
    Teofili L; Di Febo AL; Pierconti F; Maggiano N; Bendandi M; Rutella S; Cingolani A; Di Renzo N; Musto P; Pileri S; Leone G; Larocca LM
    Blood; 2001 Feb; 97(4):1063-9. PubMed ID: 11159538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
    Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
    Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression of hepatocyte growth factor and its receptor in brain astrocytomas].
    Chu SH; Yuan XH; Jiang PC; Li ZQ; Zhang J; Wen ZH; Zhao SY; Chen XJ; Cao CJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):835-8. PubMed ID: 15949402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.
    Stabile LP; Rothstein ME; Gubish CT; Cunningham DE; Lee N; Siegfried JM
    J Thorac Oncol; 2014 Sep; 9(9):1285-93. PubMed ID: 25057941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization.
    Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
    Histol Histopathol; 2012 Jan; 27(1):113-21. PubMed ID: 22127603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
    Chiang YY; Chow KC; Lin TY; Chiang IP; Fang HY
    Oncol Rep; 2014 Feb; 31(2):597-604. PubMed ID: 24276579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of hepatocyte growth factor and c-Met expression in extrahepatic biliary tract cancers.
    Hida Y; Morita T; Fujita M; Miyasaka Y; Horita S; Fujioka Y; Nagashima K; Katoh H
    Oncol Rep; 1999; 6(5):1051-6. PubMed ID: 10425302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling.
    Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Miyazaki K
    Ann Surg Oncol; 2007 Sep; 14(9):2600-7. PubMed ID: 17534684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
    Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma.
    Yamamoto T; Marui T; Akisue T; Nakatani T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
    Pathol Res Pract; 2004; 200(5):397-402. PubMed ID: 15239348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.